Scientists identify specific enzymes that make meningitis hard to fightFebruary 23, 2007Two enzymes in meningitis bacteria which prevent the body from successfully fighting off the disease, and make the infection extremely virulent, have been identified in new research published today. The study found that the two enzymes-which have distinct functions-work together to hamper the body's efforts to fight off the disease. Together they repair damage done to the meningitis bacteria's DNA by the body's white blood cells, which are sent to fight the infection. Understanding the part these enzymes play in the process that enables the bacteria to elude the body's natural defences could eventually help scientists develop novel new treatments for meningitis and the septicaemia it can cause. Both are extremely serious conditions with a high mortality rate, which take hold quickly and are difficult to treat-sometimes resulting in extreme measures such as limb amputation. When the meningitis bacteria enter the bloodstream, the body's natural defences send white blood cells to fight the infection. They ingest the bacteria and subject them to oxidative stress. Oxidative stress damages the base chemical compounds of the bacteria's DNA. This should lead to cell death and the defeat of the bacteria. However, the virulent meningitis bacteria are able to repair this harmful damage and are therefore unaffected by the body's defences. The research team found that the two enzymes essential to the bacteria's repair mechanism are AP endonuclease and 3'-phosphodiesterase. Contrary to the scientists' expectations, these two enzymes carry out separate functions in the DNA repair process. Professor Paul Freemont from Imperial's Division of Molecular Biosciences explains: "Scientists have long understood that the secret of meningitis' virulence lies in its ability to rearrange its DNA and thus change its external appearance to the body's immune system. Significantly our research has now demonstrated that the ability of meningitis to repair its DNA is important for its ability to survive attack from the body's immune system. This work provides an insight into the precise roles of two enzymes in mending DNA and gives us a greater understanding than ever before into why these infections are so hard for the body to fight. "We have also discovered that this novel combination of enzymes is present in a wide variety of bacteria and that it has a direct impact on the infectivity of human pathogens." Dr Geoff Baldwin from Imperial's Division of Molecular Biosciences added: "The wide importance of DNA repair to the viability of all organisms is well established. However, for the first time this research shows an important role for DNA repair in meningitides fighting off the attack of the body's immune system. "We have examined two enzymes from a family that are known to cut the DNA during its repair. To our surprise we discovered that in the meningitis bacteria, one of the enzymes does not cut the DNA. Instead, it removes damaged DNA ends that prevent the DNA from being remade during the repair process. This has an important impact for our understanding of the precise pathways of DNA repair and the significance of the two separate functionalities that act in different DNA repair pathways within the pathogen." Professor Christoph Tang from Imperial's Division of Investigative Science added: "After realising that the two enzymes had distinct roles repairing different types of DNA damage, were able show the pathogen can 'fend off' different types of DNA damage while in the bloodstream. In theory, finding some way of disabling these enzymes would render the bacteria unable to repair itself, and therefore vulnerable to attack and defeat by the body's immune system." Imperial College London |
|||||||||||||||||||||
| Related Meningitis Current Events and Meningitis News Articles Progress made on group B streptococcus vaccine Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus (GBS) infection is possible. Scientists create NICE solution to pneumonia vaccine testing problems Medical clinics the world over could benefit from new software* created at the National Institute of Standards and Technology (NIST), where a team of scientists has found a way to improve the efficiency of a pneumonia vaccine testing method developed at the University of Alabama at Birmingham (UAB). Review: Pneumococcal conjugate vaccines effective at preventing child deaths A study published in The Cochrane Review this month concludes that pneumococcal conjugate vaccines (PCV), already known to prevent invasive pneumococcal disease (IPD) and x-ray defined pneumonia, was also effective against child deaths. Immune cells predict outcome of West Nile virus infection Infection with West Nile virus (WNV) causes no symptoms in most people. However, it can cause fever, meningitis, and/or encephalitis. What determines the outcome of infection with WNV in different people has not been determined. UCF professor finds new way deadly food-borne bacteria spread University of Central Florida Microbiology Professor Keith Ireton has uncovered a previously unknown mechanism that plays an important role in the spread of a deadly food-borne bacterium. New WHO data underscores global threat of the world's leading child killer New World Health Organization data to be published in this week's edition of the Lancet will shed new light on two leading causes of pneumonia, the world's leading killer of children under age 5, both globally and within specific countries. How meningitis bacteria attack the brain A specific protein on the surface of a common bacterial pathogen allows the bacteria to leave the bloodstream and enter the brain, initiating the deadly infection known as meningitis. Microbes and their hosts -- exploring the complexity of symbiosis in DNA and cell biology The unique association between microorganisms and their hosts, whether insects, plants, or mammals, provides a fascinating view into how microbial symbionts adapt to changing biological environments. Breast cancer drug shows promise against serious infections An FDA-approved drug used for preventing recurrence of breast cancer shows promise in fighting life-threatening fungal infections common in immune-compromised patients, such as infants born prematurely and patients with cancer. Ben-Gurion U discovers drug can prevent epilepsy following traumatic brain injury Dr. Alon Friedman, a neurosurgeon, professor and researcher at Ben-Gurion University of the Negev, working with researchers from UC Berkeley, California have identified a TGF Beta Blocker that when given to rats prevents epilepsy after brain damage. More Meningitis Current Events and Meningitis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||